Chagas disease is an anthropozoonosis caused by Trypanosoma (Schizotrypanum) cruzi (Chagas, 1909) . It is estimated that 16 to 18 million people are infected with the parasite in 19 Latin American countries, and that approximately 50,000 individuals will die annually due to Chagas disease 1 . In Brazil, approximately 5 million people are infected with T. cruzi, with 60% residing in urban areas, similar to other countries 2, 3 . Despite a signifi cant decrease in the incidence of T. cruzi infection in humans, numerous chronic chagasic patients still receive medical attention and are treated in such reference centers as the University Hospital of the Universidade Federal do Paraná 4 . Asymptomatic T. cruzi carriers with positive serology and blood donors with inconclusive serology are often identifi ed in blood banks. Considering that these individuals do not present clinical signs and receive no defi nitive diagnosis, it is possible that such individuals carry antibodies against another Trypanosomatidae, including T. rangeli.
The World Health Organization recommends two methods that use different principles and different antigens to determine a serological diagnosis of T. cruzi infection 5 . The indirect immunofl uorescence antibody test (IFAT) and the enzymelinked immunosorbent assay (ELISA) are widely used due to the diffi culty of directly visualizing the parasite in chronic patients 6 . However, serological cross-reactivity may reduce the sensitivity of these tests in regions where other Kinetoplastida (Leishmania spp. and T. rangeli) parasites are present 7 . Molecular diagnostic methods have enabled the more precise identifi cation of pathogenic agents; indeed, such molecular techniques as the polymerase chain reaction (PCR) have improved diagnostic specifi city and the ability to identify the type of parasite circulating in a specifi c area 6, [8] [9] [10] . With regard to Chagas disease, however, PCR has presented highly variable levels of sensitivity. The reasons for this include variations in the sample volume and sample preservation, the methods used for DNA extraction, the primers selected, the quality of the reagents, the thermocycling conditions and the intermittent presence and quantity of circulating parasites
11
.
METHODS
Regardless, PCR is more sensitive than parasitological methods 12 and can be introduced as an auxiliary technique for diagnosing Chagas disease in patients with inconclusive serology. In this work, serology, hemoculture and PCR techniques were simultaneously performed in an attempt to verify the presence of T. cruzi in patients with the chronic, acute and indeterminate forms of disease. Trypanosoma rangeli was also investigated in patients with positive serology who were negative by PCR for T. cruzi.
Study population
All the individuals enrolled in the study signed a term of informed consent and filled out an epidemiological questionnaire.
One hundred and six patients from 10 to 89 (average 55.32) years of age were enrolled in this study. Eighty eight out of these came from different endemic areas of Chagas disease of the State of Paraná, Brazil and also fi ve patients from an outbreak in Santa Catarina, six from São Paulo, three from Minas Gerais, three from Rio Grande do Sul and one from Bahia. We included 15 non-infected individuals as negative controls.
Venous blood (30mL) was collected using a vacutainer system (Becton Dickinson) for the following assays: a) 5mL for serology; b) 5mL in ethylenediaminetetraacetic acid (EDTA) for DNA extraction and PCR; c) 20mL in EDTA for hemoculture. All the patients were surveyed in different medical specialties at the UPFR University Hospital.
Serological assays
The IFAT assays were performed using IFI-Imunocruzi®, Fluoline M® and Fluoline G® kits (bioMérieux) in accordance with the manufacturer's instructions. Each serum sample was diluted (1/20-1/2560) in phosphate-buffered saline (PBS), pH 7.2 and incubated for 30min at 37°C with T. cruzi epimastigotes pre-adsorbed onto immunofluorescence glass slides. The unbound immunoglobulins were removed by washing the slides twice with PBS, followed by incubation with fl uoresceinlabeled anti-human IgG or IgM conjugates at 37°C for 30min; the unbound conjugates were removed by washing with PBS. The slides were mounted with buffered glycerin (pH 9.5) and were observed under a fl uorescence microscope at 400x magnifi cation (Olympus BH2). Positive and negative sera were used as controls. The cutoff for IFI was 1/40.
ELISA was performed using the commercial kit Chagatek® (bioMérieux) in accordance with the manufacturer's recommendations. Briefl y, sera were diluted 1/20 in phosphatebuffered saline-Tween 20 (0.05%) containing 1% bovine serum albumin. A 200µL aliquot of diluted serum was added to the wells of a microtiter plate and incubated for 30min at 37°C. After 6 washes in 0.1M PBS to remove the unbound immunoglobulin, the samples were incubated at 37°C with a 1:10 dilution of peroxidase-labeled an anti-human IgG conjugate. Following another washing step, the microplates were detected with the addition H 2 O 2 in 50mM citrate buffer (pH 3.2) and 0.01mM TMB in 0.1N HCl. After a 20min incubation at room temperature, the reaction was stopped by the addition of 2N sulfuric acid. The absorbance of the samples was measured at 450nm using a microplate reader. The mean absorbance of the negative controls plus 0.100 was used for determining the cutoff, in accordance with the manufacturer's instructions. A borderline ELISA result was defi ned as reactivity within 2 standard deviations of the control.
Hemoculture
Hemoculture was performed as proposed by Kopp 4 . Briefl y, 20mL of heparinized venous blood was collected from each individual in a vacutainer system and centrifuged at 600 x g for 30min at 4°C. The plasma was collected and stored at -20°C. The buffy coat was resuspended in lmL of physiological serum at 0.9% and distributed into 10 tubes containing CCS medium. The cultures were maintained at 28°C and examined weekly over a three-month period. The positive cultures were divided into two aliquots: the fi rst was grown in LIT medium supplemented with 10% fetal bovine serum for DNA extraction of the parasite, and the remaining aliquot was cryopreserved in liquid nitrogen (-196°C).
DNA extraction
DNA was extracted from two sources: from the epimastigotes of positive cultures and from the patients' blood. The parasites obtained from cultures were washed twice with PBS, and the resulting pellet was stored at -20°C until use. DNA extraction was performed using the protocol proposed by Sambrook et al. 13 , and the resulting the DNA was stored at -70°C until use. DNA extractions from the patients' blood and artifi cially contaminated blood were achieved by the BOOM method using a Nuclisens® kit (bioMérieux, France). Briefl y, 10µL of buffy coat was resuspended in 900µL of lysis buffer (guanidine thiocyanate buffer solution, 5mol/L) and maintained at 4°C overnight. Then, 50µL of silica gel was added; following homogenization, the mixture was centrifuged for 3min at 10,000 x g. The supernatant was discarded, and the silica containing the immobilized DNA was subjected to successive washing steps to remove any contaminants. The DNA was eluted from the silica and stored at -20°C until use.
PCR technique
To perform the specifi city and sensitivity tests, authenticated negative samples were contaminated with parasites from cultures in LIT medium. The T. cruzi, T. rangeli, Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis strains were used to determine specificity. The positive controls consisted of 20ng of T. cruzi or T. rangeli DNA, and the negative controls consisted of a reaction mixture without DNA.
PCR amplifi cation of the repetitive nuclear sequence using primers TCZ1 and TCZ2
Amplifi cation reactions were performed in a fi nal volume of 25µL containing 10mM Tris-HCl (pH 8. USA). Different amounts of DNA extracted from the patients' blood (2, 4, and 8µL) or 20ng of culture DNA was then added. The cycle amplifi cation was performed using a Thermo Hybaid thermal cycler with the following conditions: 5min at 94°C (initial denaturation), 35 cycles of 1min at 95°C, 1min at 65°C and 1min at 72°C and a fi nal extension of 5min at 72°C. The primer sequences used were TCZ1, 5'CGAGCTCTTGCCCACACGGGTGCT3', and TCZ2, 5'CCTCCAAGCAGC GGATAGTTCAGG3'.
PCR amplifi cation of the P542 repetitive sequence of T. rangeli using primers R1 and R2
Amplifi cation reactions were performed in a fi nal volume of 25µL containing 10mM Tris-HCl (pH 8.3), 1.0mM MgCl 2 , 50mM KCl, 0.01% gelatin, 100µM each dNTP, 12.5 pmol each primer, 1U Taq DNA polymerase and 4µL of DNA extracted from the patients' blood or 20ng of culture DNA. The cycling conditions used were as follows: 5min at 94°C (initial denaturation); 2 cycles of 1min at 94°C, 1min at 65°C and 1min at 72°C; 10 cycles of 1min at 94°C, 1min from 65°C to 55°C, with a decrease of 1°C in each cycle, and 1min at 72°C; 18 cycles of 1min at 94°C, 1min at 55°C and 1min at 72°C and a fi nal extension of 5min at 72°C.
The primer sequences used were R1 (F), 5'CGC GGCTCGCACTGCACCTC3', and R2, (R) 5'GGC GCATCCACCGAGCACTG3'.
For all the reactions, the amplifi ed products were subjected to 1.6% agarose gel electrophoresis, stained with ethidium bromide, visualized under UV light and digitally recorded.
Statistical analysis
The degree of agreement between the serology and PCR results was determined by calculating the Kappa (k) values with 95% confi dence intervals. The analysis of agreement test was analyzed using web-based software developed by Laboratório de Epidemiologia e Estatítisca (FAFESP), which is available online at http://lee.dante.br/pesquisa/kappa/ kappaupload. 
Serological diagnosis
The comparative results of the two serological methods and PCR for the diagnosis of Chagas disease are shown in Table 1 . Using the ELISA approach, 89 of 106 patients presented positive IgG antibodies. Ten (9.43%) patients presented borderline absorbance and were considered inconclusive cases; the samples with inconclusive serology were all blood bank donors. All the patients that were positive by IFAT were also positive by ELISA, except for the patients with acute disease. Two patients who presented IgM titers of 1/40 and 1/80 had no detectable antibodies by ELISA. All the negative controls were below the cutoff.
Hemoculture
Of the 106 hemocultures conducted using the buffy coat from patients presenting positive serology, eleven (10.4%) were positive. These cases permitted the isolation of fi ve T. cruzi strains. Ten cultures were isolated from chronic patients and one from an acute case.
Validation and sensitivity of PCR for Trypanosoma cruzi and Trypanosoma rangeli
The sensitivity of PCR for the primer pair TCZ1/TCZ2 was determined using negative blood that was infected with the epimastigotes of the reference strain. As expected, amplifi cation of the 188-bp genetic fragment occurred at all dilutions. Therefore, the technique was sensitive enough to detect a single parasite in 10mL of blood. The specifi city analysis showed that TCZ1/TCZ2 amplifi ed DNA from T. cruzi (strain 152 Y and isolate HC45), T. rangeli, L. braziliensis and L. amazonensis. Therefore, we conclude that this primer pair permits the amplifi cation of PCR fragments from parasites belonging to the order Kinetoplastida (Figures 1A and 1B) .
Evaluation of the sensitivity of primer pair R1/R2 showed that it was able to detect DNA of a single parasite. Amplifi cations were conducted with cultures of various trypanosomatids (T. rangeli, T. cruzi and Leishmania) to determine specifi city.
As expected, the T. rangeli cultures were positive when using primer pair R1/R2, whereas the T. cruzi cultures were all negative. Only one culture of L. (L.) amazonensis was positive using these primers, but the amplifi cation signal was weak, showing 90% specifi city (Figures 2A and 2B) .
Patient evaluation using the PCR technique
When using the primer pair TCZ1/TCZ2, the expected 188-bp band (Figure 3 ) was detected in 81 of the 106 Chagas patients. Sixty-nine of these patients presented positive PCR and serology, and nine showed inconclusive or positive serology in only one of the serological assays. Two of the seronegative patients were positive by PCR.
None of the individuals with inconclusive serology presented the expected T. rangeli band when their blood was subjected to 
cruzi).
Electrophoresis was performed using a 1.6% agarose gel. bp: base pairs. PCR using primer pair R1/R2. None of the negative controls showed amplifi cation fragments specifi c for T. cruzi.
Comparison of molecular and serological methods
Data from the 106 patients were considered to determine the sensitivity and specifi city of the laboratory methods in question ( Table 1 ).
The sensitivity of IFAT was 81.7% for the cardiac form of the disease and 100% for patients with the digestive and indeterminate clinical forms. For patients from epidemic areas presenting acute disease, 80% were diagnosed using IFAT IgM measurement. The ELISA technique showed 100% sensitivity for patients with the digestive and indeterminate forms of the disease; the sensitivity was 76.7% for patients with the cardiac form. PCR using primer pair TCZ1/TCZ2 showed 76.4% (81/106) positivity for the cardiac patients. A specifi city of 100% was observed for all the tests. 
DISCUSSION
The World Health Organization has recently recognized Parana State in southern Brazil as an intradomiciliary transmission-free zone for T. cruzi. However, the parasite has been circulating among humans in chronic cases 14 , and a sylvatic cycle with risks of occasional transmission has been registered 15 .
Routine diagnostic techniques in reference laboratories, such as the Central Laboratories (LACENs), are necessary to assist chronic patients or those with an undetermined diagnosis. The techniques used in this work aimed to determine safer means to confi rm or invalidate a diagnosis of Chagas disease.
The IFAT technique was sensitive and specifi c, and ELISA produced inconclusive results more frequently than IFAT. This fi nding can be explained by the fact ELISA is a qualitative rather than a quantitative test. Nonetheless, serological tests are the gold standard, even for the diagnosis of chronic T. cruzi infection, due to their high sensitivity and specifi city and because antibody levels remain elevated even decades after infection [16] [17] [18] [19] . In this study, hemoculture presented only 10.4% positivity, and the positivity rate is known to vary by geographical region and the stage of illness. While, Luz et al. 20 observed 90% positivity in untreated chronic chagasic patients and Fernandes et al. 21 observed 76% positivity among children infected with T. cruzi from the state of Rio Grande do Sul. Indeed, parasitological methods usually present low sensitivity during the chronic phase of Chagas disease 12, 22, 23 . Trypanosoma cruzi parasitemia is highly variable, and this biological feature can affect the results of parasitological methods.
The positivity rate was 76.4% using primer pair TCZ1/ TCZ2 to detect T. cruzi DNA by PCR (81/106). According to the clinical classifi cation, the sensitivity of PCR varied from 33.3% to 96.5% (Table 1) . Diagnosis was confi rmed by PCR in fi ve patients presenting inconclusive serology by ELISA but compatible epidemiology (living in an endemic area), the result was negative by PCR in three cases with inconclusive serology and with no accompanying epidemiology. Different rates of PCR sensitivity have been reported in the literature. Steindel et al. 24 demonstrated 100% positivity by PCR for 19 patients from an outbreak of acute Chagas disease in Navegantes, Santa Catarina State. Fernandes et al. 23 showed PCR positivity of 86.7% in a study performed with 240 asymptomatic chronic chagasic patients from the state of Rio Grande do Sul.
The primer pair TCZ1/TCZ2 amplifi es a contiguous 188-bp segment of tandem, repetitive DNA sequences, i.e., on the same chromosome. This characteristic allows for an 'all or nothing' phenomenon when only a fraction of the extracted DNA is analyzed 25 . For this reason, all the samples presenting a negative PCR result were repeated twice using a higher DNA concentration, which resulted in a 50% increase in positivity. Picka et al. 26 reported that PCR was the technique most likely to resolve inconclusive serology for chagasic infections. PCR also constitutes an excellent tool for T. cruzi detection among transplant or immunosuppressed patients, as antibodies are often absent in these cases. Because T. cruzi takes advantage of suppressed immunity, PCR is the laboratory method of choice to detect circulating parasites, without exacerbating Chagas disease in organ transplant patients.
Recently, an international survey 11 evaluated PCR methods for the detection of T. cruzi, showing large variations in accuracy and a lack of quality controls worldwide among the 48 reviewed PCR studies. This international collaborative study was launched by expert PCR laboratories from 16 countries from which the four best performance tests were evaluated. The results indicated the limitations of PCR for the diagnosis of patients with chronic disease, and the authors 11 recommended PCR only for posttreatment follow-up, the diagnosis of congenital disease in newborns, post-organ transplantation control, AIDS patients and oral transmission patients.
Importantly, chronic patients with negative serology were positive by conventional PCR in our study. Nevertheless, our analysis used fresh blood samples instead of samples that had been stored at 4°C for two years, as was performed by Schijman et al 11 .
Public health service reference laboratories (LACENs) are responsible for the diagnosis of infectious diseases, and, as recommended by the Ministry of Health 27 , two or more methodologies must be available to confi rm a diagnosis of Chagas disease. As these laboratories regularly receive many samples awaiting diagnosis confi rmations, a standardized PCR method would be very useful.
Our data show that PCR constitutes an auxiliary methodology for the laboratory diagnosis of individuals rejected by blood banks due either to inconclusive serology for T. cruzi or when one of the gold standard serology techniques is negative. None of the patients who were positive by serology and negative by PCR for T. cruzi (TCZ1/2) were positive for T. rangeli.
